Laryngeal cancer risk in Caucasians is associated with alcohol and tobacco consumption but not modified by genetic polymorphisms in class I alcohol dehydrogenases ADH1B and ADH1C, and glutathione-S-transferases GSTM1 and GSTT1

被引:53
作者
Risch, A
Ramroth, H
Raedts, V
Rajaee-Behbahani, N
Schmezer, P
Bartsch, H
Becher, H
Dietz, A
机构
[1] German Canc Res Ctr, Div Toxicol & Canc Risk Factors, DKFZ, D-69009 Heidelberg, Germany
[2] German Canc Res Ctr, Div Clin Epidemiol, DKFZ, D-69009 Heidelberg, Germany
[3] Heidelberg Univ, Div Trop Hyg & Publ Hlth, Heidelberg, Germany
[4] Heidelberg Univ, Hals Nasen Ohren Klin, D-6900 Heidelberg, Germany
来源
PHARMACOGENETICS | 2003年 / 13卷 / 04期
关键词
laryngeal carcinoma; glutathione-S-transferase; alcohol dehydrogenase; molecular epidemiology; genotyping; tobacco and alcohol associated risk;
D O I
10.1097/00008571-200304000-00007
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objective Alcohol and tobacco consumption are recognized risk factors for upper aerodigestive tract tumours, however individual susceptibility to these environmental factors varies. As part of the Rhein-Neckar Larynx-case-control study, this study investigated the potential risk-modifying effect of genetic polymorphisms in enzymes involved in ethanol and tobacco carcinogen metabolism for laryngeal cancer in Germany. Methods Two hundred and forty-five cases and 251 population-based controls, matched by age and gender, were genotyped for genetic polymorphisms in ADH1B, ADH1C, GSTM1 and GSTT1, using genomic DNA isolated from peripheral lymphocytes and employing PCR and PCR/restriction fragment length polymorphism-based methods. Results Neither the putative risk genotypes ADH1B*21* 1 (OR 0.86, 95% confidence interval (CI): 0.41-1.82) or ADH1C* 1/* 1 (OR 1.06, CI 0.7-1.62) nor GSTM1 null (OR 0.94, CI 0.62-1.42) or GSTT1 null (OR 1.34, CI 0.74-2.42) were associated with an overall increased risk for laryngeal cancer. Stratified analyses were carried out to determine the gene-environment interaction in relation to laryngeal cancer risk. However, ADH1B or ADH1C genotypes did not markedly modify the risk observed after stratification by alcohol consumption, and stratification by cumulative smoking exposure (in packyears) did not show an association of GSTM1 or GSTT1 genotype with laryngeal carcinoma either. Conclusion The lack of risk modification by the studied genotypes emphasizes the importance of environmental exposure to tobacco smoke and alcohol as major risk factors for laryngeal cancer in the German study population.
引用
收藏
页码:225 / 230
页数:6
相关论文
共 36 条
[1]  
[Anonymous], 1999, IARC Monogr Eval Carcinog Risks Hum, V71 Pt 2, P319
[2]   Genetic polymorphism of alcohol dehydrogenase in Europeans:: The ADH2*2 allele decreases the risk for alcoholism and is associated with ADH3*1 [J].
Borràs, E ;
Coutelle, C ;
Rosell, A ;
Fernández-Muixi, F ;
Broch, M ;
Crosas, B ;
Hjelmqvist, L ;
Lorenzo, A ;
Gutiérrez, C ;
Santos, M ;
Szczepanek, M ;
Heilig, M ;
Quattrocchi, P ;
Farrés, J ;
Vidal, F ;
Richart, C ;
Mach, T ;
Bogdal, J ;
Jörnvall, H ;
Seitz, HK ;
Couzigou, P ;
Parés, X .
HEPATOLOGY, 2000, 31 (04) :984-989
[3]  
Bouchardy C, 2000, INT J CANCER, V87, P734, DOI 10.1002/1097-0215(20000901)87:5<734::AID-IJC17>3.3.CO
[4]  
2-5
[5]  
BRUGERE J, 1986, CANCER, V57, P391, DOI 10.1002/1097-0142(19860115)57:2<391::AID-CNCR2820570235>3.0.CO
[6]  
2-Q
[7]  
Chao YC, 1997, HEPATOLOGY, V25, P112
[8]   POLYMORPHISM OF ALCOHOL AND ALDEHYDE DEHYDROGENASE GENES AND ALCOHOLIC CIRRHOSIS IN CHINESE PATIENTS [J].
CHAO, YC ;
LIOU, SR ;
CHUNG, YY ;
TANG, HS ;
HSU, CT ;
LI, TK ;
YIN, SJ .
HEPATOLOGY, 1994, 19 (02) :360-366
[9]   Laryngeal and oropharyngeal cancer, and alcohol dehydrogenase 3 and glutathione S-transferase M1 polymorphisms [J].
Coutelle, C ;
Ward, PJ ;
Fleury, B ;
Quattrocchi, P ;
Chambrin, H ;
Iron, A ;
Couzigou, P ;
Cassaigne, A .
HUMAN GENETICS, 1997, 99 (03) :319-325
[10]   Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family [J].
Duester, G ;
Farrés, J ;
Felder, MR ;
Holmes, RS ;
Höög, JO ;
Parés, X ;
Plapp, BV ;
Yin, SJ ;
Jörnvall, H .
BIOCHEMICAL PHARMACOLOGY, 1999, 58 (03) :389-395